- Home
- EVM vs ABEO Comparison
EVM vs ABEO Comparison
Compare EVM & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVM
- ABEO
- Stock Information
- Founded
- EVM 2002
- ABEO N/A
- Country
- EVM United States
- ABEO United States
- Employees
- EVM N/A
- ABEO N/A
- Industry
- EVM Finance/Investors Services
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- EVM Finance
- ABEO Health Care
- Exchange
- EVM Nasdaq
- ABEO Nasdaq
- Market Cap
- EVM 233.7M
- ABEO 277.6M
- IPO Year
- EVM N/A
- ABEO 1980
- Fundamental
- Price
- EVM $9.45
- ABEO $5.86
- Analyst Decision
- EVM
- ABEO Strong Buy
- Analyst Count
- EVM 0
- ABEO 3
- Target Price
- EVM N/A
- ABEO $18.00
- AVG Volume (30 Days)
- EVM 55.8K
- ABEO 292.3K
- Earning Date
- EVM 01-01-0001
- ABEO 11-14-2024
- Dividend Yield
- EVM 4.01%
- ABEO N/A
- EPS Growth
- EVM N/A
- ABEO N/A
- EPS
- EVM 0.20
- ABEO N/A
- Revenue
- EVM N/A
- ABEO N/A
- Revenue This Year
- EVM N/A
- ABEO N/A
- Revenue Next Year
- EVM N/A
- ABEO $7,097.06
- P/E Ratio
- EVM $47.61
- ABEO N/A
- Revenue Growth
- EVM N/A
- ABEO 147.52
- 52 Week Low
- EVM $7.67
- ABEO $3.05
- 52 Week High
- EVM $9.59
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- EVM 56.53
- ABEO 38.62
- Support Level
- EVM $9.25
- ABEO $5.95
- Resistance Level
- EVM $9.36
- ABEO $6.78
- Average True Range (ATR)
- EVM 0.08
- ABEO 0.32
- MACD
- EVM 0.03
- ABEO -0.07
- Stochastic Oscillator
- EVM 94.03
- ABEO 7.07
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.